Diverse pre-filtered compound library for computational screening and testing
A curated subset of 10,000 diverse structures from Key Organics' stock collection, pre-filtered by molecular weight (<500) and logP (<5). This compound library is designed for computational screening followed by experimental testing, offering a fruitful collaboration opportunity for pharmaceutical and agrochemical discovery programs.
Overview
Key Organics is offering a diverse subset of 10,000 structures from its proprietary Bionet stock collection, pre-filtered using drug-like property criteria (molecular weight below 500 and logP below 5). These compounds were originally designed and synthesized for a range of different research purposes, making the collection structurally diverse and suitable for broad screening applications. The library is intended to support computational screening workflows followed by experimental testing, enabling partners to identify novel hits and starting points for drug discovery or agrochemical development.
Technical specifications
Library composition:
- 10,000 diverse structures selected from Key Organics' Bionet stock collection
- Pre-filtered using molecular weight (<500) and logP (<5) drug-like property criteria
- Compounds originally synthesized for varied research purposes, providing structural diversity
- Option to expand the library with additional molecules meeting the same MW/logP filters at a later stage
Screening approach:
The proposed workflow involves computationally screening the pre-filtered stock collection to prioritize compounds, followed by experimental testing of selected candidates. This approach aims to maximize the efficiency of hit identification by combining in silico prioritization with empirical validation.
Technology readiness level
The compound library is immediately available from existing stock, and additional compounds meeting the same property filters can be uploaded as needed. The library is ready for computational screening and subsequent experimental testing in collaboration with interested partners.
About key organics
Key Organics is a UK-based contract research organization (CRO) founded in 1986 that provides specialized chemistry services to the global life sciences, pharmaceutical, agrochemical, and biotechnology sectors. The company integrates its research and development capabilities—including custom synthesis, process development, and scale-up—with Bionet, a proprietary collection of over 330,000 research intermediates, fragments, and screening compounds. By combining these discovery and manufacturing offerings, the company supports projects from hit identification and lead optimization through to pre-clinical development. Their expertise spans multi-step synthesis, heterocyclic chemistry, and the creation of stable-labeled compounds, supported by in-house analytical testing and quality accreditation.
These services enable pharmaceutical and biotechnology partners to accelerate drug discovery timelines and overcome complex synthetic challenges. Key Organics serves as a vital partner for companies seeking reliable chemical procurement and bespoke chemical solutions, often working on projects that require strict adherence to purity specifications and rapid turnaround. Following a management buyout in 2025, the company continues to operate as an independent entity from its headquarters in Camelford, Cornwall, maintaining a focus on delivering agile, high-quality chemical services and innovative compound products to an international customer base.
delivered to your inbox.